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Multi-day endurance sports expose athletes to multiple physical stressors. Little is known about the 
athletes’ physiological responses to these stressors. A detailed understanding of the serological 
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Objective: 
This prospective, observational study aims to characterize serological changes in AR athletes across 
multi-day competition.  
 
Methods:  
Athletes underwent venipuncture at the start, mid-point, and end of a 5-day, multi-discipline event. A 
variety of serological and inflammatory factors were measured and then analyzed to describe their 
changes over the course of the race.  
 
Results: 
27 AR athletes (29.6% female, 70.4% male) met inclusion criteria out of 33 recruited initially. The 
mean age was 37.7 (IQR 32.5, 41) The median race-time for athletes was 133 hours (IQR 123, 142). 
Serum creatinine, sodium and potassium tended to remain stable as the race progressed. Conversely, 
serological measures, including haemoglobin, interleukin-6 and C-reactive protein levels, tended to 
change substantially during the race.  
 
Conclusions: 
Participants demonstrated the ability to maintain homeostasis, despite significant physiological threat. 
Renal function, electrolyte balance and hormonal profiles were stable. However, a pro-inflammatory 
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1. Introduction.  
Multi-day adventure racing is a relatively young sport, undertaken by mixed-sex teams of 4 athletes 
continuously racing more than 72-hours. Participants race supported only by their teammates, and 
must use a variety of methods, such as mountain biking, kayaking, and trail running, to navigate the 
race. Multi-day adventure racing shares many physiological and technical demands with traditional 
endurance events such as triathlons, Ironman®, and ultra-marathons. However, adventure racing 
poses additional challenges to the athletes, including the longer duration, the absence of a support 
crew to optimize nutrition and hydration, significant sleep deprivation, and the cognitive demands of 
navigating a demanding course under these circumstances. Furthermore, environmental conditions, 
particularly large swings in ambient temperature, may place additional demands on the athletes.  
 While the short-term intensity of exercise during multi-day adventure racing tends to be lower 
than that of events such as the triathlon, the prolonged duration of physical and mental effort presents 
risks to both professional and amateur competitors alike. The total energy expenditure for a fit male 
during an expedition-length race is approximately 10,000 to 13,000 kilocalories per day (1), making it 
difficult for athletes to consume enough water and nutrients to meet the physiological demands of the 
race (2). Previous evidence suggests that exercise intensity in multi-day adventure racing is more than 
60% of heart rate reserve in the first 12 hours of a race, before progressively falling to approximately 
40% of heart rate reserve at 24 hours, which is usually sustained until race completion (3, 4).  
These stresses can have knock-on effects on the risk of illness. At the 2005 adventure racing 
World Championship, the incidence of illness within the race was reported to be one per 1,000 race-
hours (5). This is a seemingly low rate of health related events but it is tempered by the prolonged 
race-hour exposure of 16,774 hours during the event. Furthermore, it is estimated that up to 12% of 
adventure racing athletes sustained a new illness within 1 week of race completion (5). This rate is 
significantly higher than the 5% illness rate reported by athletes during the 2016 Summer Olympics 
(6). The majority of illnesses relate to gastro-intestinal and respiratory disturbance (7), though 
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Several studies have reported that endurance exercise induces an acute phase inflammatory 
response similar to that seen in sepsis and trauma (9). Cytokines mediate this inflammatory response 
to exercise and their release during exercise is known to be affected by exercise intensity and duration 
(10). The endothelial and muscular disruption encourages the migration of leukocytes to the area of 
injury. This local reaction induces a systemic inflammatory reaction known as the acute phase 
response. This response includes the production of a large number of hepatocyte-derived acute phase 
proteins, such as C-reactive protein (CRP) (11). Pederson offers a comprehensive review of the topic 
of the exercise-induced inflammatory cytokine response in his summary article Exercise and 
Cytokines (Pederson). After a marathon race Tumour Necrosis Factor alpha (TNF- α) and Interleukin 
1β ( IL-1β) levels increase twofold and Interleukin 6 (IL-6) levels increase up to 100-fold. This is 
followed by a marked increase in the concentration of Interleukin 1 receptor alpha ( IL-1ra). This 
release of pro-inflammatory mediators is balanced by the release of cytokine inhibitors (IL-1ra and 
TNF receptors) and the anti-inflammatory cytokine Interleukin 10 (IL-10). In addition, the 
concentrations of the chemokines Interleukin 8 (IL-8), macrophage inflammatory protein -1α (MIP-
1α) and MIP-1β are elevated after a marathon. These findings suggest that cytokine inhibitors and 
anti-inflammatory cytokines tightly restrict the magnitude and duration of the inflammatory response 
to exercise as previously thought. The presence of multiple cytokines (TNF-α, IL-1β, IL-6, IL-2 
receptors and interferon-γ) in the urine following exercise provides further evidence of that a broad 
spectrum of cytokines are expressed in response to exercise (9) 
To date, there has been little research on the physiological adaptations of adventure racing 
athletes during multi-day races. The increasing popularity and competitiveness of the sport underlines 
the importance for attending medical teams and sports medicine practitioners to understand the 
physiological stressors that competing athletes may experience so that they can plan and treat 
accordingly (1). The aim of this study is to thus describe the physiological profiles of athletes during 
an expedition-length adventure race. The authors hypothesis that a significant pro-inflammatory 
response will be noted in adventurer racers as is seen in other prolonged endurance exercise above but 
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illness reported in this athlete group. This study will help us to better understand the physiological 
demands of these events, allow us to identify areas of potential harm to this athlete population, and to 
ultimately enhance medical provision at adventure racing events. To do this, we profiled the 
haematological, biochemical, hormonal, and immunological alterations occurring in adventure racing 
athletes competing in the ITERA Adventure Racing World Series event held in the West of Ireland in 
August 2016. Here, we describe the serological changes throughout the grueling 5-day race in the 
largest cohort of adventure racing athletes measured to date. 
 
2. Materials and Methods 
2.1 Study Design and Setting 
This observational study was prospective in design and included participants in the 2016 ITERA 
Expedition Race, one of ten races that take place each year in the Adventure Race World Series. This 
continuous, 5-day expedition-length adventure race took place on the west coast of Ireland from the 
17th to 21st August 2016. The event involved 33 mixed-sex teams from nine different countries. The 
race covered 579 km of nonstop racing, over five days, across five Irish counties. This included 293 
km mountain biking, 156 km on foot (running and trekking over 3 separate mountain ranges), 130 km 
on kayaks in open seas and lakes, a total climb of 15000 m which took in the summits of the highest 
and second highest mountains in Ireland, and additional challenges such as coasteering, cave 
navigation and swimming. 
 
2.2 Study Population 
All registered participants of the ITERA race were invited to take part in the study via email and 
social media. To be included in the study, the participants needed to be a registered competitor for the 
ITERA Expedition Race 2016 that completed more than one full day of racing. The exclusion criteria 
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term medication, and pregnancy. Eligible participants were provided with written information about 
the purposes and details of the study in advance of enrollment. All athletes were required to provide 
written informed consent prior to enrollment. Enrolled participants could withdraw at any time. The 
Clinical Research Ethics Committee of the Cork Teaching Hospitals (CREC) approved the study prior 
to commencement. 
 
2.3 Data Collection 
2.3.1 Participant Characteristics 
A preliminary session was held at race registration to measure participant weight and height, from 
which body mass index (BMI) was calculated. Height was measured using a free-standing 
stadiometer. Weight was measured using calibrated electronic scales placed on a hard level surface. 
Participants completed a pre-race survey that included age, sex, nationality, team country of origin, 
presence or absence of team sponsorship, previous adventure race experience (including only races of 
greater than 24 hours duration), background medical history, current medications, and illness or injury 
resulting from previous expedition racing. Athletes were asked to describe their typical weekly 
training volume during the competitive season. This was recorded in hours of activity per day. Final 
race position and total race time were recorded from the race website upon publication of the official 
ITERA Adventure Race results.  
 
2.3.2 Blood sampling 
Blood sampling took place at race registration, at a midrace transition zone on day 2 -3 of racing 
(kayaking to mountain bike stage), and at the finish line. The final blood sampling and a second 
weight measurement were taken on race completion within 30 minutes of crossing the finish line. 
Trained personnel performed venous blood sampling from the antecubital vein. One 3ml K3EDTA, 
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fluoride/K3EDTA vacutainer tubes (Vacuette®, Greiner Bio-One GmbH, Kremsmünster Austria) 
were taken at each sampling time point. Athletes were monitored for 5 minutes after each sampling 
episode to observe for any ill-effects. 
 The 2-ml sodium fluoride/K3EDTA vacutainer tubes were immediately frozen on crushed ice. 
The 9ml K3EDTA samples stored at 0-4°C during the sampling period, prior to transfer to the 
laboratory for plasma cytokine measurement. All other samples were maintained at room temperature. 
All samples for cytokine analysis were transferred to the laboratory within 6 hours of blood draw. On 
arrival, these samples were centrifuged at 2,000g for 20 minutes and plasma was aliquoted into plain 
2ml vials stored at -80°C.  
 
2.3.3 Outcome analysis 
All samples were processed in the relevant departments (biochemistry and haematology) in the 
clinical sciences laboratory of Cork University Hospital, Cork City, Ireland. This large, university 
teaching hospital laboratory conducts a significant quantity of clinical blood testing using 
standardized methodology and regular quality control. Extensive haematological, biochemical, 
hormonal, and lipid profiles were performed in additional to inflammatory marker testing including 
C-reactive protein. The concentrations of subjects’ circulating inflammatory cytokines including 
interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10) and tumour necrosis factor alpha 
(TNF-α) in plasma supernatant were determined using Meso Scale Discovery multi-spot analyte 
micro-plates (Rockville, Maryland, USA). This system is an electrochemiluminesence-based solid-
phase multiplex assay. Specifically, the ultra-sensitive human pro-inflammatory I, V-Plex 
immunoassay panel, was used. Stored samples were allowed to thaw fully at room temperature before 
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2.4 Statistical Methods 
2.4.1 Descriptive Statistics 
Categorical variables were described by their counts and percentages in each category. Continuous 
variables were described by their means and standard deviations, by their medians and inter-quartile 
ranges, and by their full ranges, where appropriate.  
 
2.4.2 Estimation of Trends 
Trajectories for each outcome over the three time points were estimated in an exploratory manner 
using linear mixed effects models with a random intercept for athlete to account for the clustered 
nature of the data. First, for each outcome, two models were estimated: one that included linear time 
in the model (coded as 0/1/2) and one that did not. Models were estimated with maximum likelihood 
estimation, and the likelihood ratio test (LRT) of the nested models was used to evaluate the 
importance of the inclusion of time in the model. Where the LRT chi squared p value was > 0.05, it 
was concluded that there was no appreciable time trend in that outcome, and these were labeled as no 
trend. 
  For the remaining outcomes, a second set of models were estimated: one that included linear 
time in the model (as before), and another that also included time squared, to capture any quadratic 
trends. Again, the LRT of the nested models was used to evaluate the importance of the quadratic 
term the model. Where the LRT chi squared p value was > 0.05, it was concluded that the trend could 
be adequately described as linear; otherwise the trend was described as quadratic. All models were 
further adjusted for sex and age. The trends for each outcome were also plotted for each participant to 
verify conclusions from the mixed effects models. Prior to model estimation, the distributions of each 
outcome at each time point were visually inspected to determine if a log-transformation would be 
helpful. All analyses were conducted using the R Project for Statistical Computing (Version 3.2.2). 
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3. Results 
3.1 Sample population characteristics 
A total of 33 athletes initially enrolled in the study (28 expressed interest by email in advance of the 
race; 5 volunteered on the day of race registration). Six athletes withdrew or did not meet the 
inclusion/exclusion criteria. The final sample population comprised 27 athletes from 11 teams (20% 
of the total race population). This was made up of 19 males and 8 females, which matched the 3:1 
ratio of males to females in most adventure racing teams. Sixty-three percent of study participants 
received sponsored external aid either through direct finance or equipment. The study group was 
predominantly made up of experienced adventure racers, with 77.8% of participants having 
previously raced in at least one similar race. The average time spent training was 10.7 hours per week 
(range 3 –20 hours). Anthropometric and demographic characteristics of the sample population are 
outlined in Table 1.  
 
The median time spent racing was 133 hours (5.5 days). 7.4% of the sample finished the entire race 
(long course) achieving all mandatory checkpoints. 37% of enrolled athletes were converted to the 
short course. 11.1% (n=3) of our sample retired before completion of the race. 24 athletes (88.8%) 
were measured at all 3 time points. Those who retired did so after the second time point, and were not 
sampled at race completion. The highest placed team in the study population finished 6th and the 
lowest was 32nd.  
 
3.2 Effects of time on outcome variables 
Tests of a linear time trends across the outcomes are given in Figure 1. For most outcomes, the mixed 
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Among the outcomes where the p-value for the test of a linear time trend was < 0.05, we then tested 
whether the inclusion of a quadratic time effect would further improve model fit. These tests for 
quadratic time trends across all outcomes are given in Figure 2. For most outcomes, the inclusion of a 
quadratic time effect improved model fit, based on the p-value of the LRT chi-squared test of the 
nested models.  
 
3.3 Effect of sustained physical exertion on the haematological profile of adventure racers  
Haemoglobin concentration decreased linearly as the race progressed (Fig. 3). The pattern is 
consistent with destruction or loss of red blood cells through hemolysis caused by race trauma 
(concurrent increase in serum bilirubin levels). The decrease in haemoglobin was mirrored with a 
proportional decline in both haematocrit and red blood cell (RBC) values. Mean cell volume (MCV) 
remained unchanged suggesting the fall in haemoglobin was not the result of blood loss.  
Total white blood cell (WBC) count, predominantly composed of neutrophils and 
lymphocytes, increased from baseline during the race and remained elevated in keeping with an acute 
phase inflammatory response. Both lymphocyte and neutrophil numbers increased from baseline to 
midrace but lymphocyte response decreased below baseline by the finish line whereas neutrophils 
remained slightly elevated (mean concentrations outlined in supplementary Table 1). 
 
3.4 Effect of sustained physical exertion on the renal function and electrolyte balance of 
adventure racers  
Overall, athletes’ electrolytes and renal function remained tightly regulated throughout the race (Table 
2). Serum urea trended upwards as athletes progressed through the race indicating the presence of 
dehydration in the competitors. However, serum creatinine levels remained relatively unperturbed, 
suggesting an ability to preserve renal function in the face of prolonged physical effort. All 
electrolytes including sodium, potassium, phosphate and magnesium showed no apparent change in 
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3.5 The effect of sustained physical exertion on the liver function of adventure racers  
Liver function tests can be divided into the direct assessment of liver enzymes (Alanine 
aminotransferase (ALT); total bilirubin (tBili)) and the assessment of synthetic liver function 
(albumin and hydroxylation of cholecalciferol to active vitamin D). In response to prolonged 
strenuous exertion, ALT and tBili levels demonstrated a marked curved elevation with progression of 
race time possibly reflecting hepatic insult (Figure 4). Serum albumin, an indicator of hepatic 
synthetic function followed a declined linearly. Vitamin D levels were stable throughout the race 
(mean values presented in supplementary Table 2).  
 
3.6 Effect of sustained physical exertion on hormonal levels of adventure racers. 
Analysis of serum cortisol levels did not appreciable change over the course of the race (Table 3). 
Thyroid stimulating hormone (TSH) linearly increased, while free thyroxine (fT4) levels decreased, 
during the race. However, overall values for thyroid function tests remained within normal limits for 
both genders.  
 
3.7 The effect of prolonged exertion on serological markers of muscle damage and circulating 
inflammatory cytokines in adventure racers.  
Figure 5 demonstrates a distinct rise in serum creatine kinase levels (CK) mid-race with a subsequent 
downward trend towards normal at the end of the race. At baseline CK levels were within normal 
limits in all athletes, peaking mid-race in 78% of the sample with a subsequent downward trend 
towards normalization at race end. Conversely, venous lactate levels remained within normal limits 
throughout the race (Table 4). 
 A marked change in inflammatory cytokine levels occurred during the multi-day adventure 
race (Table 4 and Figure 6). Significant elevations were noted in circulating IL-6, IL-8 and to a lesser 
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protein and total white cell count. Conversely, the anti-inflammatory cytokine IL-10 remained stable 
throughout all measured time points. Interpretation of these results suggests that the evident elevation 
in IL-6 and IL-8 in this cohort of adventure racers results in a pro-inflammatory effect.  
 
4. Discussion  
4.1 Overview of the findings 
Here, we describe the physiological alterations reflected in haematology, biochemical, hormonal and 
inflammatory profiles of adventure racers during a continuous 5-day adventure race event. Our cohort 
of athletes was representative of usual adventure racing participants, comprising a mixture of 
experienced and inexperienced athletes, both professional and amateur, with a gender ratio consistent 
with other races. As has been described previously, the anthropometric characteristics of our study 
population were comparable to those seen in triathletes (1). This race was an Adventure Race World 
Series championship event, a highly competitive race, featuring some of the world’s best adventure 
racing athletes. Approximately three quarters of the study participants reported competing previously 
in similar races. The winning time of 90 hours was indicative of a race which had a slightly slower 
pace than the average for the 6 other races in the series (81 hours) reflecting a challenging course; and 
unseasonable, inclement weather (wind and rain) which challenged the athletes throughout the week. 
 The results highlight the demand placed on athletes’ homeostatic mechanisms during such 
events, but also serve to reassure event medical teams of a robust ability amongst racers to preserve 
organ function despite prolonged physical and psychological stressors. First, our results indicate a 
significant decline in total red cell number and haemoglobin concentration as the raced progressed. In 
several respects, this is unsurprising considering increased iron loss through sweat production in 
combination with increased haemolysis secondary to recurrent trauma and foot strike during exercise. 
This phenomenon has been described previously in runners (13). Despite the reduction in 
haematological parameters, clinically significant quantities of blood loss or reductions in haemoglobin 
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control throughout the event. While the presence of warm weather may have led to different 
outcomes, it is reassuring that athletes maintained stable levels of renal function under severe 
physiological stress. During extended endurance exercise splanchnic blood flow to intra-abdominal 
organs is reduced, diverting blood to actively respiring tissues i.e. lungs, cardiac and skeletal muscle 
(14). Despite this, hepatic function remained relatively stable across the race. Hepatic production of 
albumin, and hydroxylation of cholecalciferol by the liver, indicated by serum vitamin D levels, 
remained relatively stable throughout the 5-day event. While a mild rise in serum alanine 
aminotransferase (ALT) and total bilirubin levels were evident as the race progressed (supplementary 
table 2), mean levels did not increase greater than twice the upper limit of normal. These findings can 
be explained by increased ALT leak from damaged skeletal muscle tissue (15), and increased 
haemolysis of red cells causing hyperbilirubinaemia respectively (13). Furthermore, hormonal 
assessment indicated maintained thyroid stimulation and thyroxine production throughout the race.  
 
4.2 Changes in inflammatory profiles in athletes during multi-day adventure racing 
In our study, the statistical models suggested that IL-6 levels were the most sensitive biomarker to 
time spent exercising. We cannot be certain that the sustained IL-6 elevation seen in our cohort is 
definitively a pro-inflammatory effect as it is known to exert pleiotropic effects bringing about 
positive and negative physiological adaptions depending on the tissue it is produced in.  However the 
concurrent increase in other pro-inflammatory markers and absence of increase in Il-10 suggests that 
it may be operating an inflammatory as well as a metabolic effect during exercise of this type (16-18). 
In the acute period immediately following exercise, circulating interleukin-6 levels surge following 
release from contracting skeletal muscle tissues. Increases in IL-6 levels post-exercise offer distinct 
functions to its more traditional pro-inflammatory effect when released from immune cells (19). The 
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In this study, cytokine and inflammatory marker dynamics depict a clear and acute 
inflammatory response to exercise that was maintained until race-end. For all athletes, a marked 
increase in circulating levels of IL-6, IL-8, creatine kinase, TNF-, C-reactive protein and total white 
cell count was evident as the race progressed. Furthermore, levels of IL-10, a cytokine with 
predominantly anti-inflammatory actions, remained stable throughout the race. This suggests that IL-6 
release in our study is predominantly pro-inflammatory in nature. These findings suggest that 
extended physical activity, such as that which occurs during adventure racing, leads to a measurable 
and unopposed pro-inflammatory response. Previously, evidence has demonstrated that increases in 
circulating levels of TNF-α are evident only after extreme forms of exercise (21, 22). In the current 
analysis, levels of TNF-α rose appreciably in a curved manner highlighting the magnitude of physical 
exertion and the degree of inflammatory stress elicited by this form of exercise.  
 The potential effects of the described inflammatory response to athletes’ health are unclear. 
However, awareness of this phenomenon is important for medical staff who may be treating adventure 
racing athletes who are injured or unwell. Previous analysis has demonstrated the negative 
psychological effects resulting from lipopolysaccharide-induced IL-6 release, leading to depressed 
mood, malaise and fatigue (23, 24). Work by Anglem et al. has demonstrated the occurrence of 
altered mood states in adventure racing athletes persisting for up to 2-weeks following expedition-
length races (7). Whether the sustained IL-6 and pro-inflammatory responses demonstrated during 
multi-day competitions are directly responsible for mood disruption in adventure race athletes is 
plausible but is currently unproven. Furthermore, the contribution of sleep deprivation to these effects 
may be disparate to those physiological effects caused by prolonged aerobic activity. The examination 
of cytokine dynamics in the period following multi-day adventure races may provide useful 
information in this regard in the future.  
In addition, extreme and unaccustomed physical effort, as seen in multi-day adventure racing, 
predisposes athletes to elevated risk of infectious disease. Spikes in immune cell activity (e.g. natural 
killer cells) resulting from intense, prolonged physical activity is frequently followed with a transient 
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previously been illustrated in adventure racing (7) and is supported by the immunological profiles of 
the present study.  
 
4.3 Strengths and limitations of the study 
The major strength of the study was the comprehensive measurement of serological changes of 
adventure racers using high-quality procedures in a real-life field setting. Further, the presence of pre-
race testing allowed for accurate assessment of changes in measured variables as the race progressed 
which adds strength to the study. The study is limited by its observational and exploratory nature; and 
by the relatively small but heterogeneous sample, which limits the generalizability of the findings.  
 
5. Perspective 
Adventure racing is a unique sport with a multitude of substantial environmental, physiological, 
psychological and cognitive stresses that result in each athlete performing at the limits of their 
capabilities. Multi-day, expedition-length races expose both experienced and non-experienced 
participants to the health risks of sustained endurance activity in the setting of extreme sleep 
deprivation. This study indicates that participating athletes can preserve internal organ homeostasis 
despite extreme physical stress over a 5-day period. Pro-inflammatory cytokine dynamics during this 
race indicate an acute and sustained inflammatory response to continuous physical exertion. Potential 
negative effects of such responses are unknown, but may affect athlete’s mood, innate immune 
function, and infection risk. Further study of adventure racing athletes in the days to weeks post-race 
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Figures/Tables 
 




Mean ± SD 
Or 
N (%) 
Median [IQR] (Min, Max) 
Sex 27 
   
Female  8 (29.6%)   
Male  19 (70.4%)   
Age (years) 27 37.8 ± 8.1 36 [32.5, 41] (24, 62) 
Weight (kg) 27 73.9 ± 9.5 74.5 [68.3, 79.8] (55.5, 93) 
Height (m) 27 1.7 ± 0.1 1.8 [1.7, 1.8] (1.6, 1.9) 
BMI (kg/m2) 27 24.1 ± 2 24.5 [22.7, 25.2] (20.6, 28) 
Sponsored 27    
No  10 (37%)   
Yes  17 (63%)   
Course type 27    
Full  2 (7.4%)   
Non-competitive   12 (44.4%)   
Retired  3 (11.1%)   
Short  10 (37%)   
Finishing place 27 18.5 ± 8.3 19 [11, 25] (6, 32) 
Finish time (hours) 27 125 ± 27.8 133 [123, 142] (57, 166) 
Previous experience 27    
No  6 (22.2%)   
Yes  21 (77.8%)   
Training time  
(hours per week) 
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The plot displays the LRT chi-squared p-value for each outcome, comparing two, nested linear mixed 
effects models: a model with no effect of time, and a model with a linear effect of time. The null 
hypothesis is that the inclusion of the time effect does not improve model fit. Low p-values suggest 
discordance between the observed data and the null hypothesis. P-values are plotted on the log 10 
scale to help distinguish values very close to zero. A p-value of 0.05 is highlighted by the dashed-line.   
alt alanine aminotransferase, ast aspartate aminotransferase, ck creatine kinase, crp c-reactive 
protein, free.t4 free thyroxine, hdl high density lipoprotein, il6 interleukin-6, il8 interleukin 8, il10 
interleukin 10, ldl low density lipoprotein, rbc red blood cell count, tnd.a tumour necrosing factor 
alpha, tsh thyroid stimulating hormone, vitd vitamin d,  vldl very low density lipoprotein , wbc white 
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The plot displays the LRT chi-squared p-value for each outcome, comparing two, nested linear mixed 
effects models: a model with a linear effect of time, and a model that adds a quadratic effect of time 
(i.e. time squared). The null hypothesis is that the inclusion of the quadratic effect does not improve 
model fit. Low p-values suggest discordance between the observed data and the null hypothesis. P-
values are plotted on the log 10 scale to help distinguish values very close to zero. A p-value of 0.05 is 
highlighted by the dashed-line.  
alt alanine aminotransferase, ck creatine kinase, crp c-reactive protein, free.t4 free thyroxine, hdl 
high density lipoprotein, il6 interleukin-6, il8 interleukin 8, il10 interleukin 10, ldl low density 
lipoprotein, rbc red blood cell count, tnd.a tumour necrosing factor alpha, tsh thyroid stimulating 














This article is protected by copyright. All rights reserved. 
Fig. 3 – Trajectories for haematological indices 
 
 
Caption: The plots display individual trajectories, as well a summary of these trajectories (the heavier 
line), by sex. For outcomes labelled as no trend or linear, the summary trajectory is estimated by 
ordinary least squares. For outcomes labelled as quadratic, it is estimated with a local regression 
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Table 2. Summary of mean renal and electrolyte panel results 
   
Start  Mid-race  End  
Normal 
Range 










Urea F 8 5.3 ± 0.6 8 6 ± 1.8 7 5.8 ± 1.9 mmol/L 2.8-8.4 
 M 19 5.9 ± 1 19 7.6 ± 1.6 16 7.1 ± 2.2   
Creatinine  F 8 63 ± 4.3 8 62.2 ± 4.2 7 69.9 ± 5.9 umol/L 64-104 
 M 19 76.5 ± 8.8 19 77.4 ± 9.9 16 73.2 ± 8.3   
Phosphate F 8 1.2 ± 0.2 8 1.3 ± 0.2 7 1.2 ± 0.1 mmol/L 0.8-1.5 
 M 19 1 ± 0.2 19 1.1 ± 0.2 16 1.1 ± 0.2   
Magnesiu
m 
F 8 0.9 ± 0 8 0.9 ± 0.1 7 0.9 ± 0.1 mmol/L 0.7-1 
 M 19 0.9 ± 0.1 19 0.9 ± 0.1 16 0.9 ± 0.1   
Calcium F 8 2.4 ± 0.1 8 2.3 ± 0.1 7 2.3 ± 0.1 mmol/L 2.1-2.65 
 M 19 2.4 ± 0.1 19 2.4 ± 0.1 16 2.3 ± 0.1   
Sodium F 8 137.5 ± 
1.3 
8 137.6 ± 
1.7 
7 137.7 ± 
1.7 
mmol/L 132-144 
 M 19 139.3 ± 
1.5 
19 139 ± 1.6 16 138.2 ± 
1.5 
  
Potassium F 8 4.1 ± 0.3 8 3.9 ± 0.5 7 4 ± 0.2 mmol/L 3.5-5.1 
 M 19 4.2 ± 0.3 19 4 ± 0.4 16 4.1 ± 0.4   
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Fig. 4 – Trajectories for liver function tests 
 
Caption: The plots display individual trajectories, as well a summary of these trajectories (the heavier 
line), by sex. For outcomes labelled as no trend or linear, the summary trajectory is estimated by 
ordinary least squares. For outcomes labelled as quadratic, it is estimated with a local regression 
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Item Sex N Mean±SD  N Mean±SD N Mean±SD Units 
 
Cortisol F 8 328 ± 147 8 271 ± 92.8 7 245 ± 90.9 nmol/L 
 
 
M 19 339.5 ± 98.8 19 336.5 ± 108 16 287 ± 82.2 
  
Free T4 F 8 13.8 ± 2.4 8 15.1 ± 2 7 15.2 ± 1.9 pmol/L 9-19.1 
 
M 19 14.6 ± 1.2 19 15 ± 1.7 16 14.8 ± 1.5 
  
TSH F 8 1.7 ± 1.2 8 2.2 ± 0.8 7 1.2 ± 0.6 mIU/L 0.35-4.94 
 M 19 1.6 ± 0.9 19 1.8 ± 0.9 16 1.4 ± 0.9 
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Table 4. Variation in mean inflammatory and serological muscle damage biomarkers. 












Item Sex N Mean±SD  N Mean±SD N Mean±SD Units  

















Lactate F 8 1.4 ± 0.4 8 1 ± 0.2 7 1.3 ± 0.5 mmol/L 0.5-2.2 
 M 19 1.2 ± 0.4 19 1.3 ± 0.6 16 1.3 ± 0.5   
TNF-α F 8 1.8 ± 0.3 8 2.4 ± 0.6 7 2.1 ± 0.5 pg/ml  
 M 19 2.5 ± 0.7 19 2.8 ± 0.55 16 2.9 ± 0.7   
IL-10 F 8 0.3 ± 0.1 8 0.5 ± 0. 2 7 0.4 ± 0.2 pg/ml  
 M 19 0.6 ± 1 19 0.6 ± 0.3 16 0.6 ± 0.2   
IL-8 F 8 3.8 ± 3 8 6.0 ± 4.5 7 7.9 ± 5.8 pg/ml  
 M 19 1.9 ± 5.7 19 6.9 ± 5.2 16 9.6 ± 4.4    
IL-6 F 8 0.56 ± 0.2 8 3.48 ± 2.6 7 2.3 ± 1.2 pg/ml  
 M 19 0.4 ± 0.5 19 4.8 ± 5 16 4.4 ± 2.7   
CRP F 8 0.63 ± 0.2 8 11.4 ± 6.1 7 6.9 ± 2.6 mg/L 0-10 
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Fig. 6 – Trajectories for cytokines, C-reactive protein and total white cell count. 
 
Caption: The plots display individual trajectories, as well a summary of these trajectories (the heavier 
line), by sex. For outcomes labelled as no trend or linear, the summary trajectory is estimated by 
ordinary least squares. For outcomes labelled as quadratic, it is estimated with a local regression 
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Appendices 
Supplementary Table 1. Summary of haematological results. 
   Start  Mid-race  End  Range 
Item Sex N Mean±SD N Mean±SD N Mean±SD Units 
 
Haemoglobin F 8 13.3 ± 1.2 8 12.7 ± 1.1 7 12.2 ± 1.7     g/dL 11.7-15.9  
 M 19 15 ± 0.9 19 14.1 ± 0.9 16 13.3 ± 0.6  13 - 17 
Haematocrit F 8 0.4 ± 0 8 0.4 ± 0 7 0.4 ± 0  0.35-0.46  
 M 19 0.4 ± 0 19 0.4 ± 0 16 0.4 ± 0  0.38 – 0.49 
RBC F 8 4.5 ± 0.4 8 4.3 ± 0.3 7 4.1 ± 0.3 x1012/L  3.9 – 5.3 
 M 19 4.9 ± 0.4 19 4.7 ± 0.4 16 4.5 ± 0.3  4.2 – 5.6 
MCV F 8 88.7 ± 7.6 8 87.7 ± 6.9 7 87.9 ± 8 fL 80 - 96 
 M 19 87.7 ± 4.3 19 86.3 ± 3.8 16 87.5 ± 3.4  80 - 96 
WBC F 8 6.2 ± 1 8 9.4 ± 2 7 8.5 ± 3.1 x1012/L  4.4 – 11.3 
 M 19 5.7 ± 1.5 19 9.3 ± 2.5 16 8 ± 2.6  4.4 – 11.3 
Lymphocytes  F 8 1.9 ± 0.6 8 2.3 ± 0.7 7 1.7 ± 0.8 x109/L  0.9 - 3.2 
 M 19 1.8 ± 0.4 19 1.8 ± 0.5 16 1.5 ± 0.5  0.9 – 3.2 
Neutrophils F 8 3.6 ± 0.8 8 6.1 ± 2.3 7 5.9 ± 3.3 x109/L  1.4 - 6.6 
 M 19 3.3 1.1 19 6.5  ± 2.2 16 5.7 ± 2.2  1.4 – 6.6 
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ALT alanine aminotransferase, tBili total bilirubin, Vit. Vitamin, SD standard deviation. 
 
 
















F 8 17.1 ± 4.7 8 55.4 ± 
64.1 
7 63.7 ± 53 U/L 0-45 
 
M 19 28.9 ± 
18.3 
19 57.4 ± 24 16 71 ± 24   
tBili  




M 19 12.8 ± 4.7 19 22.05 ± 
8.3 
16 18.7 ± 6.4   
Albumi
n 
F 8 45 ± 2.8 8 43.9 ± 2.2 7 43.1 ± 1.2 g/L 35-52 
 
M 19 47.5 ± 2.1 19 46.5 ± 2.3 16 45.1 ± 2   
Vit. D  






M 19 78.3 ± 
19.1 
17 79.5 ± 
16.8 
16 77.3 ± 
22.2 
  
          
